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Abstract: Female genital schistosomiasis is a neglected tropical disease caused by
Schistosoma haematobium. Infected females may suffer from symptoms mimicking sexually
transmitted infections. We explored if self-reported history of unsafe water contact could be used
as a simple predictor of genital schistosomiasis. In a cross-sectional study in rural South Africa,
883 sexually active women aged 16–22 years were included. Questions were asked about urogenital
symptoms and water contact history. Urine samples were tested for S. haematobium ova. A score based
on self-reported water contact was calculated and the association with symptoms was explored while
adjusting for other genital infections using multivariable logistic regression analyses. S. haematobium
ova were detected in the urine of 30.5% of subjects. Having ova in the urine was associated with the
water contact score (p < 0.001). Symptoms that were associated with water contact included burning
sensation in the genitals (p = 0.005), spot bleeding (p = 0.012), abnormal discharge smell (p = 0.018),
bloody discharge (p = 0.020), genital ulcer (p = 0.038), red urine (p < 0.001), stress incontinence
(p = 0.001) and lower abdominal pain (p = 0.028). In S. haematobium endemic areas, self-reported water
contact was strongly associated with urogenital symptoms. In low-resource settings, a simple history
including risk of water contact behaviour can serve as an indicator of urogenital schistosomiasis.
Keywords: Schistosoma haematobium; female genital schistosomiasis; water contact; urogenital
symptoms; sexually transmitted infections
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1. Introduction
It is estimated that more than 112 million people worldwide are infected with the freshwater
parasite Schistosoma haematobium [1]. S. haematobium is thought to be the main etiological agent of
urogenital schistosomiasis [2]. This disease is mostly endemic in Sub-Saharan Africa, the Middle East
and most recently an outbreak was reported in Corsica, France [3,4]. The disease is prevalent in poor
communities without access to safe water and proper sanitation [5]. Rural communities that rely on
agriculture and fishing are especially at risk as well as women and children who are using rivers for
their daily chores or recreational activities [5].
Infection with S. haematobium occurs through contact with contaminated freshwater containing the
larval form of the parasite (cercariae), which is released by the Bulinus africanus snail [6]. The cercariae
penetrate the skin, enter the bloodstream and follow it to the liver [6]. Here, they mature and mate
before they migrate as male and female couples to the venous plexa surrounding the urogenital organs
where the female starts producing ova [6]. Some of these ova are released back into the environment
through excreta while some get lodged in the urogenital organs [6]. The urogenital morbidity seen
with S. haematobium infection is largely due to the host’s immune response to the schistosome ova [6].
Female genital schistosomiasis (FGS) is defined as schistosomiasis affecting the female
reproductive tract with characteristic lesions such as grainy sandy patches, homogenous yellow
patches, rubbery papules and abnormal blood vessels [7]. FGS has been shown to be associated with
infertility, miscarriage, extrauterine pregnancies, urinary symptoms and genital symptoms mimicking
sexually transmitted infections (STIs) [2]. Furthermore, recent studies have shown that FGS may make
women more susceptible to human immunodeficiency virus (HIV) [8,9]. This might be due to due to
local inflammation of the genital mucosa, breach of the mucosal barrier and immunological changes in
the mucosa [8,9].
Several studies have found an association between water contact and schistosomiasis and have
shown that a simple questionnaire on water contact could be used to identify urogenital schistosomiasis
in S. haematobium endemic areas [10–12]. To our knowledge, there has only been one study that explored
the association between genital symptoms and water contact in an S. haematobium endemic area [13].
However, this was carried out in young girls 10–12 years of age, prior to becoming sexually active.
In S. haematobium endemic areas with limited resources FGS is an important differential diagnosis to
venereal disease and cervical cancer [2]. This study seeks to explore self-reported water contact as a
simple predictor for urogenital symptoms in young women living in a rural schistosomiasis endemic
area in South Africa.
2. Materials and Methods
2.1. Study Area
A cross-sectional study was performed in schools in three districts in KwaZulu-Natal, on the east
coast of South Africa. According to the South African census of 2011, in KwaZulu-Natal 63.6% of the
households had access to piped water in their dwelling or yard, 22.4% had access to piped water on a
communal stand and 14.1% had no access to protected water. The subtropical climate in this region
ranges from very hot, rainy summers (November–February) to cool and dry winters (June–August).
The province is endemic for S. haematobium [13,14]. We targeted schools with more than 300 pupils
situated in rural areas in Ilembe, Uthungulu and Ugu districts below the altitude of 300 m above sea
level as a sampling frame, and we randomly selected 70 schools for the study. Based on one urine
sample, 31 out of 70 schools with a prevalence of more than 20% schistosomiasis were included.
2.2. Recruiting Participants
The recruiting took place from 2011 to 2013. Included schools were visited and informed about
schistosomiasis. All female students above the age of 16 were invited to the information sessions.
Sampled by convenience, sexually active and consenting young women aged 16–22 years were invited
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for gynaecological examinations. Pregnant women, virgins and non-consenting women were excluded.
Dates for possible investigations were provided by the teachers and subsequently discussed with the
women individually.
2.3. Questionnaire
Trained research assistants performed the interviews in their local language (isiZulu) using a
questionnaire. Answers were translated into English. Questions were asked about current or previous
symptoms, such as bloody discharge, spot bleeding, genital itch, burning sensation in the genital area,
painful intercourse, lower abdominal pain, upper abdominal pain, abnormal discharge smell and
colour, red urine, pain on urination, and stress incontinence. The questionnaire also included questions
about previous treatment with Praziquantel (the standard treatment for schistosomiasis).
Rivers, dams, lakes, streams and ponds were defined as unsafe water sources. Detailed questions
were asked about lifetime exposure to the most common water-related activities in the study area
(laundry, washing blankets, playing, personal hygiene, crossing, collection of water for domestic
use, and fishing) [13,15]. Participants were shown a diagram of the human body and were asked to
describe how much of their body got exposed to water during the different water contact activities.
The percentage of the body exposure was recorded according to the rule of nines (commonly used in
body burn charts) [16]. Each water activity frequency could be graded from a maximum score of four
if they had used it “daily” to zero if they had “never” used the water body for the specific activity.
2.4. Water Contact Score
A water contact score was created for each individual based on the frequency of each activity,
duration of unsafe water contact, percentage of the body exposed and total number of years of unsafe
water contact during their lifetime.
As shown in Table 1, we quantified the estimated risk involved with each of the activities by
creating an activity risk coefficient (ARC), which was calculated based on the reported average duration
of water contact and reported percentage of the body exposed [15].
Table 1. Activity risk coefficient (ARC) for each water contact activity.
Activity Time Range (h) Median Body Surface (%) Activity Risk Coefficient
Playing 1–3 100 5
Bathing 1–3 100 5
Washing blankets 3–5 35 4
Laundry 1–3 35 3
Fishing 1–3 35 3
Collecting water ≤1 20 1
Crossing ≤1 25 1
Figure 1 shows that the prevalence of schistosomiasis increases gradually with the increased
number of years of water contact, up to six years of water contact, after which the prevalence plateaus.
Based on the number of years exposed to unsafe water, we assigned a lifetime exposure risk coefficient
(ERC) from 0 to 2, where 0 was assigned to those participants who reported no water contact, 1 was
assigned to those who reported having water contact for 1–5 years and 2 was assigned to those who
reported having had unsafe water contact for more than six years.
The compound water score was calculated for each individual by multiplying the frequency of
water contact (F) by each of the activities’ risk coefficients (ARC) and by the lifetime exposure risk
coefficient (ERC):
Water contact score = F × ARC × ERC
The water contact score was normalized to a range of 0–10 for ease of presentation.
Int. J. Environ. Res. Public Health 2016, 13, 1135 4 of 12
Int. J. Environ. Res. Public Health 2016, 13, 1135  4 of 13 
 
Water contact score = F × ARC × ERC 
The water contact score was normalized to a range of 0–10 for ease of presentation. 
 
Figure 1. Prevalence of S. haematobium ova in the urine and total number of years of unsafe water 
contact. Error bars: 95% confidence interval (CI). 
2.5. Sample Collection and Laboratory Analyses 
Consenting participants were invited for a gynaecological examination, which included 
collection of cervico-vaginal lavage (CVL) for STI analyses and Papanicolaou (Pap) smears [17]. One 
urine sample was collected from each participant between 10 a.m. and 2 p.m. [18]. For quality 
control purposes, two 10 mL urine samples were prepared for microscopy as previously described 
[14]. The presence of at least one ovum was defined as a positive diagnosis. Blood was collected (30 
mL) in sterile acid-citrate-dextrose anti-coagulated Vacutainer tubes (Becton, Dickinson and 
Company (BD), Franklin Lakes, NJ, USA) [19]. 
Neisseria gonorrhoea and Chlamydia trachomatis were detected using a strand displacement assay 
(ProbeTec CT/GC, BD) [20]. In-house PCR (Laboratory of Infection, Prevention and Control, UKZN, 
Durban, South Africa) was used for Trichomonas vaginalis [20]. Bacterial vaginosis was diagnosed 
using Nugent’s Score [21]. A score above seven was considered a positive diagnosis [22]. Syphilis 
screening was performed using rapid plasma reagin (RPR, Macro Vue test 110/112, BD), and positive 
tests were confirmed using Treponema pallidum hemagglutination assay (TPHA, Omega Diagnostics 
Group PLC, Alva, Scotland, UK) [23]. Herpes simplex type 2 antibodies were detected in serum using 
ELISA (Ridascreen HSV 2 IgG, Davies Diagnostics, Randburg, South Africa) [24]. All serology was 
done on serum samples frozen at −80 °C. Candida albicans was detected in the Pap smear by 
microscopy [25,26]. 
2.6. Ethical Considerations 
All participants signed individual, informed, written consent forms. The participants were 
made aware of their right to withdraw at any time during the study. The study was approved by the 
Biomedical Research Ethics Committee (BREC), University of KwaZulu-Natal (Ref BF029/07), 
Figure 1. Prevalence of S. haematobium ova in the urine and total number of years of unsafe water
contact. Error bars: 95% confidence interval (CI).
2.5. Sample Collection and Laboratory Anal ses
Consenting participants were invited for a gynaecological examination, which included collection
of cervico-vaginal lavage (CVL) for STI analyses and Papanicolaou (Pap) smears [17]. One urine
sample was collected from each participant between 10 a.m. and 2 p.m. [18]. For quality control
purposes, two 10 mL urine samples were prepared for microscopy as previously described [14].
The presence of at least one ovum was defined as a positive diagnosis. Blood was collected (30 mL) in
sterile acid-citrate-dextrose anti-coagulated Vacutainer tubes (Becton, Dickinson and Company (BD),
Franklin Lakes, NJ, USA) [19].
Neisseria gonorrhoea and Chlamydia trachomatis were detected using a strand displacement assay
(ProbeTec CT/GC, BD) [20]. In-house PCR (Laboratory of Infection, Prevention and Control, UKZN,
Durban, South Africa) was used for Trichomon v ginalis [20]. Bacterial vaginosis was diagnosed using
Nugent’s Score [21]. A scor above seve was consid red a posit ve diagnosis [22]. Syphilis screening
was performed using rapid plasma reagin (RPR, Macro Vue test 110/112, BD), and positive tests
were confirmed using Treponema pallidum hemagglutination assay (TPHA, Omega Diagnostics Group
PLC, Alva, Scotland, UK) [23]. Herpes simplex type 2 antibodies were detected in serum using ELISA
(Ridascreen HSV 2 IgG, Davies Diagnostics, Randburg, South Africa) [24]. All serology was done on
serum samples frozen at −80 ◦C. Candida albicans was detected in the Pap smear by microscopy [25,26].
2.6. Ethical Considerations
All participants signed individual, informed, written consent forms. The participants were
made aware of their right to withdraw at any time during the study. The study was approved by
the Biomedical Research Ethics Committee (BREC), University of KwaZulu-Natal (Ref BF029/07),
KwaZulu-Natal Department of Health (Reference HRKM010-08) and the Regional Committee for
Medical and Health Research Ethics (REC), South Eastern Norway (Ref 469-07066a1.2007.535).
The Departments of Health and Education in Ugu, Ilembe and Uthungulu districts, KwaZulu-Natal,
gave permissions for this study. The ethical committees, BREC (annual renewal) and REC, were aware
that minors, aged 16 and 17 were participating in the study and specifically approved independent
minor consent without parental consent. We followed the South African syndromic protocol to diagnose
and treat findings at the point of care. Once the laboratory results were available, patients were
Int. J. Environ. Res. Public Health 2016, 13, 1135 5 of 12
contacted for further management as required. Praziquantel was offered to all participants as part of a
Department of Health mass drug administration campaign.
2.7. Statistical Analyses
Statistical analyses were done using Statistical Package for Social Sciences (SPSS) version 22
(IBM, Chicago, IL, USA). Graphs were made using Prism version 6 (Graphpad, San Diego, CA, USA).
Univariable logistic regression was used to evaluate the association between water contact frequency,
self-reported symptoms and genital infection by calculating the odds ratio (OR) and the corresponding
95% confidence intervals (CI). Variables that were associated within a 15% significance level were
included in the multivariable logistic regression analyses (MVA). Age was included in the MVA
regardless of the significance level as this is considered an important socio-biological confounder.
3. Results
3.1. General Characteristics of the Study Population
A flowchart showing the process of including study participants is presented in Figure 2. The age
distribution within the study population is presented in Table 2. A total of 883 sexually active young
women aged 16–22 years (median age 19 years) were included in the study. Out of these included
participants, 794 individuals provided one urine sample for microscopy. S. haematobium ova were
detected in 30.5% (242/794). Only 25.3% (223/882) had received Praziquantel treatment prior to
participating in this study and 31.2% (275/882) did not know whether they had ever received treatment.
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Table 2. Age distribution of the study participants.
Age Number of Pupils (%)
16–17 214 (24.2)
18–19 397 (44.9)
20–22 272 (30.8)
Total 883
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Almost all participants, 95.7% (845/883), reported having had unsafe water contact at some
time in their lives. Of these, 94.0% (830/883) reported having had unsafe water contact for domestic
purposes and 77.2% (682/883) for recreation. The most common unsafe water contact source was
rivers (87.8%, 740/843). More than half of the participants, 52.0% (459/883), reported having current
unsafe water contact. Figure 3 shows how often the participants engaged in the different water contact
activities. Figure 4 shows the distribution of the calculated water contact score in the population.
Int. J. Environ. Res. Public Health 2016, 13, 1135  6 of 13 
 
Table 2. Age distribution of the study participants. 
Age Number of Pupils (%)
16–17 214 (24.2) 
18–19 397 (44.9) 
20–22 272 (30.8) 
Total 883 
Almost all participants, 95.7% (845/883), reported having had unsafe water contact at some time 
in their lives. Of these, 94.0% (830/883) reported having had unsafe water contact for domestic 
purposes and 77.2% (682/883) for recreation. The most common unsafe water contact source was 
rivers (87.8%, 740/843). More than half of the participants, 52.0% (459/883), reported having current 
unsafe water contact. Figure 3 shows how often the participants engaged in the different water 
contact activities. Figure 4 shows the distribution of the calculated water contact score in the 
population. 
 
Figure 3. Frequency whereby the participants engaged in different water contact activities in their 
lifetime, n = 883. 
 
Figure 4. Distribution of the calculated water contact score. The score was calculated as the 
multiplicative product of frequency of water contact, a risk coefficient assigned to the each of seven 
Figure 3. Frequency whereby the participants engaged in different water contact activities in their
lifetime, n = 883.
Int. J. Environ. Res. Public Health 2016, 13, 1135  6 of 13 
 
Table 2. Age distribution of the study participants. 
Age Number of Pupils (%)
16–17 214 (24.2) 
18–19 397 (44.9) 
20–22 72 (30.8) 
Total 883 
Almost all participants, 95.7% (845/883), reported having had unsafe water contact at some time 
in their lives. Of these, 94.0% (830/883) reported having had unsafe water contact for domestic 
purposes and 77.2% (682/883) for recreation. The most common unsafe water contact source was 
rivers (87.8%, 740/843). More than half of the participants, 52.0% (459/883), reported having current 
unsafe water contact. Figure 3 shows how often the participants engaged in the different water 
contact activities. Figure 4 shows the distribution of the calculated water contact score in the 
population. 
 
Figure 3. Frequency whereby the participants engaged in different water contact activities in their 
lifetime, n = 883. 
 
Figure 4. Distribution of the calculated water contact score. The score was calculated as the 
multiplicative product of frequency of water contact, a risk coefficient assigned to the each of seven 
Figure 4. Distrib ti l ted ater contact score. The score was calculated as the
multiplicative product of frequenc t ct, a risk coe ficient assigned to the each of s ven
common water contact activities and a risk coefficient assigned to the number of years exposed to
unsafe water. Mean = 4.94, standard deviation = 2.424, n = 883.
The pupils’ median sexual debut age was 16 years (range 10–21). Participants had a median of
two lifetime partners (range 1–13). C. trachomatis was the most common STI with a prevalence of
26.7% (217/814), followed by T. vaginalis (19.8%, 169/853) and N. gonorrhoea (12.0%, 98/814). Syphilis
was the least common STI in this study group with a prevalence of 2.1% (18/858). C. albicans was
detected in 13.5% (111/823) and bacterial vaginosis in 62.1% (484/779). The prevalence of self-reported
gynaecological and urinary symptoms is shown in Figure 5.
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3.3. Unsafe Water Contact and Self-Reported Urogenital Symptoms
Self-reported symptoms that were significantly associated with lifetime water contact score
(controlling for age and for genital infections) are presented in Table 3. The water contact score was not
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associated with bleeding after intercourse (adjusted (adj.) OR 1.08, 95% CI: 1.00–1.17, p = 0.059), painful
intercourse (adj. OR 1.05, 95% CI: 1.00–1.11, p = 0.092), abnormal discharge colour (adj. OR 1.05, 95% CI:
0.99–1.12, p = 0.090), genital itch (adj. OR 1.05, 95% CI: 0.99–1.09, p = 0.102), genital lumps (adj. OR 1.00,
95% CI: 0.92–1.08, p = 0.964), pain on urination (adj. OR = 1.05, 95% CI: 0.99–1.11, p = 0.123) and upper
abdominal pain (adj. OR 1.01, 95% CI: 0.94–1.08, p = 0.786). As shown in the Figure 5, post-coital
bleeding, upper abdominal pain and genital lumps are amongst the least common symptoms, whereas
genital itch, dyspareunia and dysuria are very common.
Table 3. Multivariable logistic regression analyses (MVA) of eight urogenital symptoms, total lifetime
water contact score, and different causal agents in an S. haematobium endemic environment. Only
genital infections exceeding a significance level of 15% were included in the MVA.
Symptom Adjusted OR 95% CI p Value a
Red urine
Water contact score b 1.16 1.09–1.24 <0.001
Neisseria gonorrhea c 1.65 1.07–2.55 0.023
Stress incontinence
Water contact score b 1.11 1.04–1.18 0.001
Neisseria gonorrhea c 1.70 1.10–2.63 0.016
Burning sensation in the genitals
Water contact score b 1.09 1.03–1.15 0.005
Neisseria gonorrhea c 1.83 1.19–2.81 0.006
Spot bleeding d
Water contact score b 1.10 1.02–1.18 0.012
Abnormal discharge smell
Water contact score b 1.07 1.01–1.14 0.018
Neisseria gonorrhea c 1.49 0.97–2.29 0.070
Bloody discharge d
Water contact score b 1.11 1.02–1.21 0.020
Lower abdominal pain e
Water contact score b 1.07 1.00–1.14 0.028
Neisseria gonorrhea c 1.46 0.91–2.35 0.119
Genital ulcer
Water contact score b 1.08 1.00–1.16 0.038
Neisseria gonorrhea c 1.63 1.01–2.64 0.045
a Multivariable logistic regression; b Calculated by multiplying water contact frequency with an estimated
activity risk coefficient and a lifetime exposure coefficient; c Strand displacement assay (ProbeTec CT/GC);
d Excluded those using hormonal contraceptives; e Excluded those currently menstruating. OR: odds ratio.
3.4. Current Unsafe Water Contact and Urogenital Symptoms
Table 4 shows a subsample of participants who were currently reporting using unsafe water.
Several symptoms that were associated with lifetime unsafe water contact were found to not be
associated with current unsafe water contact; these were bloody discharge (adj. OR 1.00, 95% CI:
0.88–1.15, p = 0.963), lower abdominal pain (adj. OR 1.08, 95% Cl: 0.98–1.20, p = 0.137) and genital
ulcers (adj. OR 1.08, 95% CI: 0.95–1.21, p = 0.238). The following symptoms were not associated
when analysing for current water contact: abnormal discharge colour (adj. OR 1.10, 95% CI: 1.00–1.22,
p = 0.061), painful intercourse (adj. OR 1.09, 95% CI: 0.88–1.15, p = 0.084) genital itch (adj. OR 1.02,
95% CI: 0.92–1.13, p = 0.717), genital lump (adj. OR 1.07, 95% CI: 0.92–1.24, p = 0.380) and upper
abdominal pain (adj. OR 1.03, 95% CI: 0.91–1.16, p = 0.677).
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Table 4. Multivariable logistic regression analyses of seven urogenital symptoms in those reporting
current water contact and different causal agents in an S. haematobium endemic environment. Only
genital infections exceeding a significance level of 15% were included in the MVA.
Symptom Adjusted OR 95% CI p Value a
Red urine
Water contact score b 1.19 1.07–1.32 0.001
Neisseria gonorrhoea c 1.46 0.75–2.83 0.266
Pain on urination
Water contact score b 1.15 1.04–1.27 0.006
Neisseria gonorrhoea c 1.93 0.93–4.01 0.078
Burning sensation in the genitals
Water contact score b 1.17 1.06–1.30 0.002
Neisseria gonorrhoea c 1.99 1.02–3.88 0.043
Stress incontinence
Water contact score b 1.17 1.05–1.30 0.004
Neisseria gonorrhoea c 1.58 0.82–3.07 0.175
Spot bleeding d
Water contact score b 1.18 1.05–1.33 0.005
Post coital bleeding d
Water contact score b 1.18 1.04–1.34 0.012
Abnormal discharge smell
Water contact score b 1.11 1.01–1.22 0.027
a Multivariable logistic regression; b Calculated by multiplying water contact frequency with an estimated
activity risk coefficient and a lifetime exposure coefficient; c Strand displacement assay (ProbeTec CT/GC);
dExcluded those using hormonal contraceptives.
4. Discussion
In a young population of women living in an S. haematobium endemic area of KwaZulu-Natal,
South Africa, we found an association between self-reported unsafe water contact and urogenital
schistosomiasis in young women (age 16–22). Our findings further confirm that there is significant
association between unsafe water contact and genital symptoms, even after adjusting for sexually
transmitted infections.
When analysing a subsample of young women, who at the time of attending the clinic, reported
to be currently relying on unsafe water contact, we found a difference in symptoms compared to the
group reporting on total lifetime exposure to unsafe water. Those with current water contact reported
bleeding after intercourse and painful urination, but not bloody discharge, genital ulcers and lower
abdominal pain, which were symptoms associated with total lifetime unsafe water contact. This may
suggest that the presentations of schistosomiasis are complex and possibly different throughout
life. Furthermore, in a chronic stage of the disease, although there may not be live worms left, old
calcified eggs may still be lodged in the mucosa, causing inflammation and recruitment of CD4 positive
cells [27].
In the same study area, Hegertun et al found an association between genital symptoms and
water contact in schoolgirls aged 10–12 years indicating that infection with S. haematobium starts in
early childhood [13]. To date, we have found only six studies that have explored the association
between gynaecological symptoms and schistosomiasis [13,28–32]. Those studies were small and
from different countries and age groups. Interestingly, the studies have also shown other urogenital
symptoms to be associated with S. haematobium infection (e.g., genital itch). In S. haematobium endemic
areas, Kjetland et al. found that S. haematobium may be the most common cause of genital morbidity
and mucosal lesions [7]. Based on these findings, we argue that in S. haematobium endemic areas,
Int. J. Environ. Res. Public Health 2016, 13, 1135 10 of 12
urogenital schistosomiasis should be considered as a differential diagnosis in all women presenting
with symptoms of sexually transmitted diseases.
More than half of the participants were still using an unsafe water source at the time of the
interview, mainly for domestic chores. Only a quarter of the participants reported having received
Praziquantel treatment at some point in their life. Furthermore, South Africa has still not implemented
a national schistosomiasis control and prevention programme. The current study area is categorized
as moderately endemic for schistosomiasis according to the World Health Organization (prevalence
of 10%–50%) [33]. Our findings indicate that there is an urgent need for public health initiatives to
educate policy makers, health care professionals as well as those who are at risk.
Limitations
There is a day-to-day variation in ova excretion and by collecting samples over several days, we
would have found a higher prevalence of S. haematobium [18]. The water bodies that have been used
by the participants have not been checked for Bulinus africanus snails shedding S. haematobium cercaria.
All the data we have gathered on symptoms and water contact history are self-reported. Although the
participants were unaware of their schistosomiasis status we cannot preclude recall bias. Furthermore,
the inaccuracy of self-reported water contact is evident from the fact that the S. haematobium prevalence
was 14% in those who denied having had unsafe water contact. Combining the questionnaire with
direct observational data could have improved the accuracy of this study [34].
The research clinic aimed at being youth-friendly and the learners were informed that female
genital schistosomiasis can be asymptomatic. However, those experiencing symptoms might be more
likely to participate in order to receive treatment [35]. Therefore, the symptoms reported by the study
population might not be truly representative of the study area. Cultural factors may have also played
a role; such as fear of being stigmatized, which may have lead to under-reporting of symptoms.
Lastly, cultural and psychological factors and chronic disease could have influenced their perception
of symptoms.
5. Conclusions
In an S. haematobium endemic area, unsafe water contact was associated with urogenital symptoms
in teenage women. It is likely that these symptoms are caused by female genital schistosomiasis
and we suggest that simple patient history taking on risk water contact behaviour may serve as a
diagnostic indicator when sophisticated diagnostic tools are unavailable. Further studies are needed
to explore whether this approach may also be applicable for older women. Moreover, studies should
be done in endemic settings to determine how to differentiate between STIs, cancer, and female genital
schistosomiasis. Regular mass drug administration of Praziquantel should be offered to those at risk,
particularly school-aged children and women.
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